Increase in H5N1 vaccine antibodies confers cross-neutralization of highly pathogenic avian influenza H5N1

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-60714-4
Affiliations:
4
Authors:
9
Go to article
Institutions Authors Share
Institute for Biological Product Control, NIFDC, China
4.000000
 0.44
Sinovac, China
2.000000
 0.22
Chinese Center for Disease Control and Prevention (China CDC), China
2.000000
 0.22
Shenyang Pharmaceutical University (SPU), China
1.000000
 0.11
Interested in Clinical Sciences?